Literature DB >> 27758826

Misidentification of Bupropion Glucuronide Metabolites and Re-evaluation of Metabolite Pharmacokinetics.

Aaron M Teitelbaum1, Evan D Kharasch2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27758826      PMCID： PMC5074474          DOI： 10.1124/dmd.116.072892

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN： 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  4 in total

1.  Withdrawal of generic budeprion for nonbioequivalence.

Authors:  Janet Woodcock; Mansoor Khan; Lawrence X Yu
Journal:  N Engl J Med       Date:  2012-12-05       Impact factor: 91.245

2.  Stereoselective Glucuronidation of Bupropion Metabolites In Vitro and In Vivo.

Authors:  Brandon T Gufford; Jessica Bo Li Lu; Ingrid F Metzger; David R Jones; Zeruesenay Desta
Journal:  Drug Metab Dispos       Date:  2016-01-22       Impact factor: 3.922

3.  Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers.

Authors:  Andrea R Masters; Brandon T Gufford; Jessica Bo Li Lu; Ingrid F Metzger; David R Jones; Zeruesenay Desta
Journal:  J Pharmacol Exp Ther       Date:  2016-06-02       Impact factor: 4.030

4.  Development, validation and application of a comprehensive stereoselective LC/MS-MS assay for bupropion and oxidative, reductive, and glucuronide metabolites in human urine.

Authors:  Aaron M Teitelbaum; Alicia M Flaker; Evan D Kharasch
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-05-24       Impact factor: 3.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.